The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay ...

Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance ...

This is a test of whether traditional Medicare can adopt the kind of utilization management long used by the private insurers ...

Sepsis is globally recognized as a primary contributor to morbidity and mortality. The Sepsis 3.0 definition is captured as ...

Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne ...

UnitedHealth rolls out AI in Optum Rx to flag pharmacy fraud, billing anomalies and medication risks, aiming to curb cost leakage and improve compliance.

The following segment was excerpted from the Harbor Health Care ETF Q4 2025 Commentary.During the fourth quarter, the Harbor ...

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2025 Earnings Call Transcript March 12, 2026 Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics, Inc. fourth quarter ...

Objective: To conduct a cost-effectiveness analysis comparing behavioral health integration (BHI) in primary care vs clinical ...

Physician adoption of ARCALYST as a second-line treatment was further supported by the 2025 ACC clinical guidance recommending IL-1 pathway inhibition after failure of NSAIDs and colchicine. Operator: ...

An Informational Analysis of TrimRx Compounded Semaglutide and Tirzepatide Programs, Telehealth Prescription Process, ...

YONGIN, South Korea, March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that a review paper comprehensively ...